ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

638
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
02 Nov 2023 15:33

Celltrion Merger Update: Limits Lifted

Initially, the stock purchase rights limit was set at 1₩tn; however Celltrion Group's founder/Chairman Seo Jung-jin has removed this limit. That...

Logo
506 Views
Share
bullishCelltrion Inc
02 Nov 2023 05:40

Celltrion Merger: Appraisal Rights & Passive Flows

The appraisal rights exercise period ends 13 Nov. Both companies are buying back shares. The last traded price is close to the appraisal price....

Logo
601 Views
Share
01 Nov 2023 07:00

(Mostly) Asia M&A, Oct 2023: Haitong, Azure, Hollysys, Aeon, Teraoka, Tietto, Lithium Power

For the month of October, 7 new deals were discussed on Smartkarma with an overall deal size of ~US$4bn. The average premium for the new deals...

Logo
474 Views
Share
01 Nov 2023 07:00

KRX Short Interest Weekly (Oct 27th): Samsung Biologic, Skc, Hotel Shilla Co, Ecopro

We analyzed KRX short interest report for the past week and highlight short interest changes in Samsung Biologic, Skc, Hotel Shilla Co, Ecopro,...

Logo
397 Views
Share
bullishJSR Corp
30 Oct 2023 02:01

Merger Arb Mondays (30 Oct) - JSR, Eoflow, Azure Minerals, Symbio, Hollysys, Haitong Intl

This week, the highest gross spreads are 111 (71.8%), Eoflow (38.2%), Hollysys (22.4%), Symbio (10.1%), JSR (9.3%), Healius (8.9%), Haitong Intl...

Logo
768 Views
Share
x